Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest update is out from Cann Group ( (AU:CAN) ).
Cann Group Limited has announced the application for quotation of 11,607,322 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 20, 2025. This move is part of the company’s strategic efforts to bolster its financial position and enhance its market presence, potentially impacting its operations and offering new opportunities for stakeholders.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is engaged in the development and commercialization of cannabis-based therapies, targeting both domestic and international markets.
Average Trading Volume: 1,675,380
Technical Sentiment Signal: Sell
Current Market Cap: A$9.77M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.